Afya Limited (NASDAQ:AFYA) Receives $17.38 Consensus Target Price from Brokerages

Afya Limited (NASDAQ:AFYA) has been assigned a consensus rating of “Hold” from the seven analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $17.3750.

Several brokerages recently weighed in on AFYA. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research report on Friday, January 16th. UBS Group reissued a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a research report on Friday, January 16th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $22.00 price objective (down previously from $24.50) on shares of Afya in a report on Wednesday, January 7th. Finally, Wall Street Zen downgraded shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 31st.

Afya Stock Performance

Afya stock opened at $14.07 on Thursday. The stock’s 50 day simple moving average is $14.78 and its two-hundred day simple moving average is $14.90. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of 10.12, a PEG ratio of 0.52 and a beta of 0.50. Afya has a fifty-two week low of $13.12 and a fifty-two week high of $19.90.

Institutional Investors Weigh In On Afya

Several hedge funds have recently added to or reduced their stakes in AFYA. Van ECK Associates Corp grew its stake in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after acquiring an additional 1,377 shares during the last quarter. Daiwa Securities Group Inc. purchased a new stake in Afya during the 4th quarter valued at about $43,000. Arrowstreet Capital Limited Partnership increased its stake in Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after purchasing an additional 3,626 shares in the last quarter. Dodge & Cox raised its holdings in Afya by 12.8% in the second quarter. Dodge & Cox now owns 35,262 shares of the company’s stock worth $630,000 after buying an additional 4,000 shares during the last quarter. Finally, Militia Capital Partners LP bought a new position in shares of Afya in the second quarter worth approximately $71,000. 88.02% of the stock is owned by institutional investors.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.